For research teamsHelp me find a study
Study directory

Bipolarity studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1909studies shown
Showing 1,285-1,296 of 1,909
Drug study icon
CompletedEUCTR 2005-004881-17

Efficacy and safety of agomelatine (25 mg/day with potential adjustment at 50 mg/day) given orally compared to placebo, in addition to a mood stabilizer in Bipolar I patients with a current major d...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Austria
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugA study involving a medication or substance.
Countries
Austria, Denmark, Finland, ...
Sponsor
Institut de Recherches Internationales Servier [...] 1. Institut de Recherches Internationales Servier 2. Laboratorios Servier S.L. (For Spain only)
Condition
Bipolarity, Depression
View study
Drug study icon
CompletedEUCTR 2014-000456-29

EFFICACY AND SAFETY OF INHALED LOXAPINE COMPARED WITH IM ANTIPSYCHOTIC IN ACUTELY AGITATED PATIENTS WITH SCHIZOPHRENIA OR Bipolarity

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Czech Republic
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, SchizophreniaDrug
Countries
Czechia, Germany, Spain
Sponsor
Ferrer Internacional, S.A.
Condition
Bipolarity, Schizophrenia
View study
Behavioral study icon
CompletedNCT02874833

Exercise for Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Mainz
Why is this study shown?

This study includes Bipolarity among several conditions.

Depression, BipolarityBehavioralFrom 18 Years to 65 Years
Countries
Germany
Sponsor
Johannes Gutenberg University Mainz
Condition
Depression, Bipolarity
View study
Drug study icon
CompletedNCT03334721

Gabapentin for Bipolar & Cannabis Use Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In Charleston
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, AddictionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Medical University of South Carolina
Condition
Bipolarity, Addiction
View study
Drug study icon
CompletedEUCTR 2012-004483-22

NACOS - The effect of N-acetylcystein for depressive symptoms in patients with bipolar depression - A double blind randomized placebo-controlled trial with follow up

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Denmark
Why is this study shown?

This study includes Bipolarity among several conditions.

Depression, BipolarityDrug
Countries
Denmark
Sponsor
Mental Health Service, Esbjerg
Condition
Depression, Bipolarity
View study
Other study type icon
CompletedNCT02360267

Pediatric Bipolar Registry

This summary needs review. Please check the official study record and contact the research team for details.

In Houston
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, Schizophrenia, ...ObservationalA study where researchers collect information without assigning a treatment.From 6 Years to 17 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Bipolarity, Schizophrenia, ...
View study
Biological study icon
CompletedEUCTR 2008-004857-14

The effects of erythropoietin on depressive symptoms and neurocognitive deficits in patients with treatment resistant depression and in patients with remitted Bipolarity – a proof of concept ...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Denmark
Why is this study shown?

This study includes Bipolarity among several conditions.

Depression, BipolarityBiological
Countries
Denmark
Sponsor
Psykiatrisk Center Rigshospitalet
Condition
Depression, Bipolarity
View study
Drug study icon
SuspendedEUCTR 2015-002106-36

The effects of JNJ-39393406 on psychometric performance and residual depressive symptoms in 80 patients with unipolar or bipolar depression: a phase II exploratory add-on double blind placebo contr...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Romania
Why is this study shown?

This study includes Bipolarity among several conditions.

Depression, BipolarityDrug
Countries
Romania
Sponsor
Clinirx Tangent Research
Condition
Depression, Bipolarity
View study
Drug study icon
Recruitment unclearEUCTR 2013-004903-37

A RANDOMIZED, 6-WEEK, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLEXIBLE DOSE, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LURASIDONE IN CHILDREN AND ADOLESCENT SUBJECTS WITH BIPOLAR I DEPR...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Bulgaria
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrug
Countries
France, United Kingdom, Bulgaria, ...
Sponsor
SUNOVION PHARMACEUTICALS INC.
Condition
Bipolarity, Depression
View study
Drug study icon
Recruitment unclearEUCTR 2021-004790-31

A Randomized, Stratified, Double-blind, Placebo-Controlled Study to Investigate the Efficacy, Safety and Tolerability of JNJ-55308942 in Bipolar Depression

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Poland
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrug
Countries
Poland, Spain
Sponsor
Janssen-Cilag International NV
Condition
Bipolarity, Depression
View study
Drug study icon
Recruitment unclearEUCTR 2017-000497-11

A Study to Evaluate the Effect of ALKS 3831 Compared to Olanzapine on Body Weight in Young Adults with Schizophrenia, Schizophreniform, or Bipolarity type I Who are Early in Their Illness

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Austria
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, SchizophreniaDrug
Countries
Austria, Germany, Italy, ...
Sponsor
Alkermes Inc
Condition
Bipolarity, Schizophrenia
View study
Drug study icon
Recruitment unclearEUCTR 2007-000479-40

Effects of quetiapine on ultrastructural hippocampal and neurochemical changes in patients with Bipolarity: searching for the antidepressant and mood stabilising neurophysiology

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrug
Countries
Germany
Sponsor
Department of Psychiatry, RWTH Aachen
Condition
Bipolarity, Depression
View study
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.